Press releases | Finanzwire

PRESS RELEASE

published on 12/17/2025 at 11:05, 5 months 1 day ago

An ambitious project to protect consumer health and promote the excellence of extra virgin olive oil FRANCE OLIVE PRODUCTION - UNAPROL
Italian consortium UNAPROL and French association FRANCE OLIVE PRODUCTION collaborate on project to ensure quality and safety of olive oil. Initiative supported by EU regulations

EU Regulations Quality Control Olive Oil Unaprol France Olive Production
PRESS RELEASE

published on 12/17/2025 at 11:05, 5 months 1 day ago

Dstny Celebrates Record-Breaking Year with 10+ International Awards for Cloud Communications Excellence
Dstny celebrates a record-breaking year with 10+ international awards for cloud communications excellence, including Platinum, Gold, and Silver honours across various categories

Technology International Awards EU Cloud Communications Dstny
PRESS RELEASE

published on 12/17/2025 at 11:00, 5 months 1 day ago

Healthcare specialist SHS Capital invests in a leading German Endoscopy Group
SHS Capital invests in leading German Endoscopy Group through SHS VI fund, aiming to strengthen growth and innovation in healthcare sector

Innovation Healthcare Investment SHS Capital Endoscopy Group
PRESS RELEASE

published on 12/17/2025 at 10:57, 5 months 1 day ago

Inside Information / Other news releases
Valerio Therapeutics appoints Prof. Eric Vivier as Observer to Board of Directors. Prof. Vivier, a renowned immunologist, will bring over 30 years of experience to drive innovative tumor treatment approaches

Board Of Directors Valerio Therapeutics Professor Eric Vivier Immunologist Tumor Treatment
PRESS RELEASE

published on 12/17/2025 at 10:40, 5 months 1 day ago

Brödernas publishes quarterly report for Jan-Sep 2025
Brödernas Group AB publishes Q3 2025 financial report with SEK 287m net sales and net leverage ratio exceeding 6.00x, leading to default event under bond terms

Financial Report Net Sales Leverage Ratio Brödernas Group AB Q3 Report
PRESS RELEASE

published on 12/17/2025 at 10:05, 5 months 1 day ago

UTI Investments Partners with FTSE Russell to Transition its Sovereign Bond ETF Benchmark
UTI Investments partners with FTSE Russell to transition its Sovereign Bond ETF benchmark from Nifty India Government FAR Index to FTSE Indian Government Bond FAR Index, reflecting global interest in India's fixed income markets

FTSE Russell UTI Investments Sovereign Bond ETF FTSE Indian Government Bond FAR Index India Government Bonds
PRESS RELEASE

published on 12/17/2025 at 09:30, 5 months 1 day ago

Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth
Topadur Pharma AG appoints Matthias Schäfer as Chief Executive Officer to lead company growth into next phase of clinical development and expansion. Dr. Reto Naef transitions to Senior Scientific Advisor

Clinical Development Chief Executive Officer Topadur Pharma AG Matthias Schäfer Scientific Advisor
PRESS RELEASE

published on 12/17/2025 at 09:30, 5 months 1 day ago

Designated Person Notification
Aperam announces Designated Person Notification regarding share transactions as per Market Abuse Regulations. Aperam is a global stainless steel player committed to the circular economy

Share Transactions Market Abuse Regulations Aperam Circular Economy Designated Person Notification
PRESS RELEASE

published on 12/17/2025 at 09:21, 5 months 1 day ago

Heidelberg Pharma: Letter from the CEO
Heidelberg Pharma CEO addresses delays in milestone payment, emphasizing continued development of TLX250-CDx and promising phase I study results for pamlectabart tismanitin (HDP-101). Financial challenges are being addressed proactively

CEO Heidelberg Pharma Milestone Payment TLX250-CDx Pamlectabart Tismanitin
PRESS RELEASE

published on 12/17/2025 at 09:05, 5 months 1 day ago

Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand

Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment

Published on 05/18/2026 at 08:01, 3 hours 28 minutes ago

Result of Fundraise
Published on 05/17/2026 at 15:20, 20 hours 9 minutes ago

China XLX Announces 2026 Q1 Results
Published on 05/16/2026 at 01:15, 2 days 10 hours ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 2 days 10 hours ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 2 days 11 hours ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate

View all ACCESSWIRE

Published on 05/18/2026 at 11:00, 28 minutes ago

swissnet Group Appoints Urs van Stiphout as Chairman of the Board of Directors
Published on 05/18/2026 at 10:35, 53 minutes ago

Aliko Dangote: African Energy Person of the Year 2026
Published on 05/18/2026 at 10:30, 58 minutes ago

Haier Named the World's Only IoT Ecosystem Brand in Kantar BrandZ Top 100 for Eight Consecutive Years
Published on 05/18/2026 at 10:30, 58 minutes ago

SafeFields and Veoneer Announce Strategic Agreement to Advance Automotive EMF Reduction Solutions
Published on 05/18/2026 at 10:00, 1 hour 28 minutes ago

ams OSRAM announces the offering of EUR 700 million senior notes and the entry into an amendment and restatement of its Revolving Credit Facility agreement

View all EQS

Published on 05/18/2026 at 11:06, 22 minutes ago

GUILLEMOT CORPORATION: Weekly report share buyback From May 11th to May 15th 2026
Published on 05/18/2026 at 08:30, 2 hours 59 minutes ago

Thales appoints Jérémie Papin Senior Executive Vice-President, Finance and Information Systems
Published on 05/15/2026 at 15:08, 2 days 20 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 18:00, 4 days 17 hours ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 17:45, 4 days 17 hours ago

Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.

View all LES ECHOS COMFI WIRE

News